š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study is to evaluate the safety and tolerability of sin...
Status
Completed
Location
PRA Health Sciences
Start Date
2015-09-15
Trial ID
NCT02742779
This is a two-part study. Part 1 is designed to find the best modified rele...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-01
Trial ID
NCT00427596
Treatments Being Tested
This phase II trial studies how well nab-paclitaxel and gemcitabine hydroch...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-21
Trial ID
NCT02427841
The purpose of this study is to assess the rate and extent of absorption of...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2017-02-06
Trial ID
NCT03010059
Treatments Being Tested
This is an open-label study to determine the pharmacokinetics, safety and t...
Status
Completed
Location
Clinical Site
Start Date
2020-12-30
Trial ID
NCT04709224
Treatments Being Tested
The purpose of the study is to compare the pharmacokinetic (PK) profiles an...
Status
Completed
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02356913
Treatments Being Tested
This study is a phase IV, two-arm, randomized, double-blind, placebo-contro...
Status
Recruiting
Location
University of Pennsylvania Center for Studies of Addiction
Start Date
2022-03-07
Trial ID
NCT05028062
Treatments Being Tested
This is a multi-centre, long term, double blind, clinical protocol for Nana...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11
Trial ID
NCT04808531
Treatments Being Tested
This research study is a Phase II clinical trial, which tests the safety an...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2015-01
Trial ID
NCT02176031
Treatments Being Tested
This is a Phase 2, double-blind, placebo-controlled study to determine the ...
Status
Completed
Location
The Indiana Clinical Trials Center,PC
Start Date
2019-06-25
Trial ID
NCT03981822
Treatments Being Tested